On 5 November 2018, the current EU GDP Guideline turned five years old. What have we learned in those five years? Have we succeeded in achieving a better protection of the integrity of pharmaceutical products and fortified patient safety? What did it mean for the R&D industry, the drug manufacturers and their service partners in the supply chain?
Logistics by Design (LbD) is a framework for logistics decision making. Using a risk based analysis it identifies the areas within the supply chain that need to be addressed to create a logistics platform that can meet the needs of patients at clinical and commercial scale.
To truly understand the distribution challenges faced by today’s pharmaceutical industry in bringing a new product to the clinical or commercial market, this four-part blog series will explore the most impacted areas of the supply chain following a temperature excursion, starting with financial costs to the clinical sponsor.
There is now a clearer vision for how IMP should be handled. Find out how the updated GDP guidelines bring clarity and accountability to IMP shipments.
Learn how World Courier's multi-year business transformation program (NOVA) will bring service enhancements and efficiencies to customers.
Rudiger Lomb, Vice President, Global Quality and Technical Compliance at World Courier, discusses the current regulatory challenges that are impacting the specialty logistics industry.
At World Courier, customer service is at the heart of our company. Watch Mattias Mineur, Sub-Regional Director Nordics, explain how World Courier provides an industry leading service and why we treat every shipment as if it was our own.
Learn why global GDP certification is important for the logistics industry and how World Courier goes beyond this framework.
Find out how to create competitive advantage by developing a fit-for-purpose supply chain that supports the market’s paradigm shift.
Manufacturers
Webinar on-demand: ensuring regulatory compliance and quality in Direct-to-Patient clinical trials. In this webinar, World Courier and Medical Research Network guide participants through the key regulatory considerations when planning direct to patient trials.
An overview of the risks inherent to global pharmaceutical logistics and the associated risk management. Get your white paper now.
Significant changes have been made in 2017, we've listed out all the changes that you need to be aware of based on the 58th edition first print of the DGR IATA book
A panel of experts discuss what it takes to be fully GxP compliant and what that means to manufacturers
Top considerations for selecting the right packaging
Ruediger Lomb, Vice President, Global Quality and Technical Compliance, AmerisourceBergen Specialty Group, shares the benefits and considerations of developing smart technology.
How are procurement teams changing the clinical trial landscape for the better?
Discover why there is a demand for more targeted logistics solutions, particularly in the clinical trials arena.
How sustainability efforts change your supply chain for the better...
Counterfeit drugs remain a supply chain risk in emerging markets
What you need to know to ensure integrity
Corruption can be a huge hurdle when it comes to global expansion. Are you ensuring best business conduct across the globe?
Thailand is becoming more like other, more developed markets in the region, and as part of the ASEAN region, it offers excellent opportunities. Growth is expected in both clinical and commercial prospects.
Ruediger Lomb, Vice President, Global Quality and Technical Compliance at World Courier, discusses the current regulatory challenges that are impacting the specialty logistics industry.
Learn how to protect your supply chain against counterfeit drugs with our white paper
In this two-part webinar, we discuss how the supply chain has evolved and how manufacturers can really get distribution right.
.jpg?h=56&iar=0&w=56&useCustomFunctions=1¢erCrop=1&hash=5C3BF081DEFE0CD4643E0D660948B3B2)
